Clinical Trials Browser

Phase 1 × Has results × necitumumab × Clear all

NCT02789345 2024-02-05

A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

Phase 1 Completed

29 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT01088464 2017-02-03

Study of IMC-11F8 in Participants With Advanced Solid Tumors

Phase 1 Completed

15 enrolled 22 charts

Neoplasms